We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+9.26%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$726B
AUM Growth
+$72B
Cap. Flow
+$18.3B
Cap. Flow %
2.52%
Top 10 Hldgs %
22.02%
Holding
4,790
New
331
Increased
3,384
Reduced
720
Closed
74

Sector Composition

Rank Sector Weight
1 Technology 23.98%
2 Financials 13.87%
3 Healthcare 13.39%
4 Consumer Discretionary 11.81%
5 Communication Services 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VVOS icon
4276
Vivos Therapeutics
VVOS
$5.7M
$235K ﹤0.01%
1,906
+1,411
+285% +$230K
ABTS icon
4277
Abits Group
ABTS
$3.02M
$234K ﹤0.01%
+701
New +$111K
IMCR icon
4278
Immunocore
IMCR
$1.72B
$234K ﹤0.01%
+5,997
New +$232K
KNDI
4279
Kandi Technologies Group
KNDI
$67.5M
$234K ﹤0.01%
39,238
ITRM
4280
DELISTED
Iterum Therapeutics
ITRM
$233K ﹤0.01%
6,740
+328
+5% +$7.11K
PMD
4281
DELISTED
Psychemedics Corporation
PMD
$232K ﹤0.01%
33,341
DXYN
4282
DELISTED
Dixie Group Inc
DXYN
$232K ﹤0.01%
79,394
FINM
4283
DELISTED
Marlin Technology Corporation Class A Ordinary Share
FINM
$232K ﹤0.01%
+24,047
New +$234K
SVM
4284
Silvercorp Metals
SVM
$2.07B
$230K ﹤0.01%
41,930
LUMO
4285
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$230K ﹤0.01%
23,192
ADER
4286
DELISTED
26 Capital Acquisition Corp
ADER
$230K ﹤0.01%
+23,758
New +$231K
HMCO
4287
DELISTED
HumanCo Acquisition Corp. Class A Common Stock
HMCO
$230K ﹤0.01%
+23,623
New +$234K
NOAC
4288
DELISTED
Natural Order Acquisition Corp. Common Stock
NOAC
$230K ﹤0.01%
+23,611
New +$235K
EBON icon
4289
Ebang International Holdings
EBON
$12.3M
$229K ﹤0.01%
2,480
+279
+13% +$31.4K
OXY.WS icon
4290
Occidental Petroleum Corp Warrants
OXY.WS
$33B
$228K ﹤0.01%
16,438
+3,629
+28% +$41.9K
ALIM
4291
DELISTED
Alimera Sciences
ALIM
$228K ﹤0.01%
25,091
+3,219
+15% +$31.6K
SVFB
4292
DELISTED
SVF Investment Corp. 2 Class A Ordinary Shares
SVFB
$228K ﹤0.01%
+23,010
New +$233K
BCYC
4293
Bicycle Therapeutics
BCYC
$269M
$227K ﹤0.01%
+7,479
New +$226K
IGIC icon
4294
International General Insurance
IGIC
$1.19B
$227K ﹤0.01%
+24,436
New +$206K
VNCE icon
4295
Vince Holding Corp
VNCE
$81.3M
$227K ﹤0.01%
22,521
CBAT icon
4296
CBAK Energy Technology Ltd
CBAT
$44.3M
$226K ﹤0.01%
48,117
DALN
4297
DELISTED
DallasNews
DALN
$226K ﹤0.01%
30,474
+1,879
+7% +$14.7K
MNTS icon
4298
Momentus
MNTS
$76.3M
$226K ﹤0.01%
+1
New +$146K
PAM icon
4299
Pampa Energía
PAM
$4.75B
$226K ﹤0.01%
14,899
+3,632
+32% +$54.9K
FFAI
4300
Faraday Future Intelligent Electric
FFAI
$15.2M
0

Similar funds

Geode Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
  • Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
  • Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
  • Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
  • Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
  • Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
  • Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.

Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.